UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) or 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
GOLDENWELL BIOTECH, INC. |
(Exact name of Registrant as specified in its charter) |
Nevada |
| 84-2896086 |
(State of Incorporation) |
| (I.R.S. Employer Identification No.) |
2071 Midway Drive Twinsburg, Ohio |
| 44087 |
(Address of principal executive offices) |
| (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered |
| Name of each exchange of which each class is to be registered |
Not applicable |
| Not applicable |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☐
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☒
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement file number to which this form relates: No. 333-236561
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class)
Item 1. Description of Registrant’s Securities to be Registered.
The description of the Common Stock of the Registrant is set forth under the caption “Description of Securities” in the Registrant’s Registration Statement on Form S-1 (File No. 333-236561) as filed with the Securities and Exchange Commission on February 21, 2020, as amended, and including any form of prospectus therein filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which description is herein incorporated by reference.
Item 2. Exhibits
Number | Description | |
(1) As filed in the Registrant’s Registration Statement on Form S-1 (File No. 333-236561) on February 21, 2020.
2 |
SIGNATURES
In accordance with Section 12 of the Exchange Act of 1934, the Registrant duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
GOLDENWELL BIOTECH, INC. (Registrant) | |||
Date: April 30, 2021 | By: | /s/ Shuang Liu | |
| Name: | Shuang Liu | |
Title: | Chief Executive Officer | ||
(principal executive officer) |
3 |